Nosocomial COVID-19 Incidence and Secondary Attack Rates among Patients of Tertiary Care Center, Zurich, Switzerland
Aline Wolfensberger
, Verena Kufner, Maryam Zaheri, Marius Zeeb, Isabelle Nortes, Peter W. Schreiber, Miriam Vazquez, Verena Schärer, Thomas Scheier, Stefan Schmutz, Elisabeth Probst, Dirk Saleschus, Michael Huber, Silvana K. Rampini, and Walter Zingg
Author affiliations: University Hospital Zürich and University of Zürich Division of Infectious Diseases and Hospital Epidemiology, Zurich, Switzerland (A. Wolfensberger, M. Zeeb, P.W. Schreiber, M. Vazquez, V. Schärer, T. Scheier, D. Saleschus, W. Zingg); University of Zürich Institute of Medical Virology, Zurich (V. Kufner, M. Zaheri, M. Zeeb, S. Schmutz, M. Huber); University Hospital Zürich and University of Zürich Department for Internal Medicine, Zurich (I. Nortes, S.K. Rampini); University Hospital Zürich Clinic of Immunology, Zurich (E. Probst)
Main Article
Figure 1
Figure 1. Incidence of admitted patients with positive SARS-CoV-2-PCR per week, including categorization hospital-associated versus community-associated, temporal trend of incidence of SARS-CoV-2 positive patients from week 40 of 2020 through week 25 of 2021. Incident cases were stratified according to European Centre for Disease Prevention and Control definitions of healthcare-associated COVID-19.
Main Article
Page created: July 31, 2022
Page updated: September 21, 2022
Page reviewed: September 21, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.